1. Home
  2. FRMM vs ELTX Comparison

FRMM vs ELTX Comparison

Compare FRMM & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$6.07

Market Cap

75.7M

Sector

Health Care

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.04

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMM
ELTX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.7M
81.2M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
FRMM
ELTX
Price
$6.07
$3.04
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$18.00
AVG Volume (30 Days)
180.0K
269.9K
Earning Date
05-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.29
EPS
N/A
N/A
Revenue
$6,547,000.00
$2,301,000.00
Revenue This Year
$183.55
N/A
Revenue Next Year
$166.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$2.66
52 Week High
$7.15
$16.00

Technical Indicators

Market Signals
Indicator
FRMM
ELTX
Relative Strength Index (RSI) 53.59 41.08
Support Level $4.90 $2.72
Resistance Level $6.47 $3.28
Average True Range (ATR) 0.44 0.17
MACD -0.02 0.12
Stochastic Oscillator 71.47 51.24

Price Performance

Historical Comparison
FRMM
ELTX

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: